PLUTONIUM
D-14
APPENDIX D
ICRP. 1984. International Commission on Radiological Protection. A compilation of the major concepts
and quantities in use by ICRP. ICRP Publication 42. Oxford: Pergamon Press.
ICRP. 1990. International Commission on Radiological Protection 1990 Recommendations of the ICRP
ICRU. 1980. International Commission on Radiation Units and Measurements. ICRU Report No. 33.
Washington, DC.
James A. 1987. A reconsideration of cells at risk and other key factors in radon daughter dosimetry. In:
Hopke P, ed. Radon and its decay products: Occurrence, properties and health effects. ACS Symposium
Series 331. Washington, DC: American Chemical Society, 400-418.
James A, Roy M. 1987. Dosimetric lung models. In: Gerber G, et al., ed. Age-related factors in
radionuclide metabolism and dosimetry. Boston: Martinus Nijhoff Publishers, 95-108.
Kondo S. 1993. Health effects of low-level radiation. Kinki University Press, Osaka, Japan (available
from Medical Physics Publishing, Madison, Wisconsin).
Kato H, Schull W. 1982. Studies of the mortality of A-bomb survivors. Report 7 Part 8, Cancer
mortality among atomic bomb survivors, 1950-78. Radiat Res 90;395-432.
Mettler F, Moseley R. 1985. Medical effects of ionizing radiation. New York: Grune and Stratton.
NCRP. 1971. Basic radiation protection criteria. National Council on Radiation Protection and
Measurements. Report No. 39. Washington, DC.
NCRP. 1985. A handbook of radioactivity measurements procedures. 2nd ed. National Council on
Radiation Protection and Measurements. Report No. 58. Bethesda, MD:
NCRP. 1993. Risk estimates for radiation protection. National Council on Radiation Protection and
Measurements. Report 115. Bethesda, Maryland
Otake M, Schull W. 1984. Mental retardation in children exposed in utero to the atomic bombs: A
reassessment. Technical Report RERF TR 1-83, Radiation Effects Research Foundation, Japan.
Rubin P, Casarett G. 1968. Clinical radiation pathology. Philadelphia: W.B. Sanders Company, 33.
UNSCEAR. 1977. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources
and effects of ionizing radiation. New York: United Nations.
UNSCEAR. 1982. United Nations Scientific Committee on the Effects of Atomic Radiation. Ionizing
radiation: Sources and biological effects. New York: United Nations.
UNSCEAR. 1986. United Nations Scientific Committee on the Effects of Atomic Radiation. Genetic
and somatic effects of ionizing radiation. New York: United Nations.
UNSCEAR. 1988. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources,
effects and risks of ionization radiation. New York: United Nations.
PLUTONIUM
D-15
APPENDIX D
UNSCEAR. 1993. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources
and effects of ionizing radiation. New York: United Nations.
USNRC. 1999. Standards for the protection against radiation, table 1004(b).1. 10 CFR 20.1004. U.S.
Nuclear Regulatory Commission, Washington, D.C.
PLUTONIUM
D-16
APPENDIX D
This page is intentionally blank.
PLUTONIUM
E-1
APPENDIX E. INDEX
absorbed dose.......................................................................................................................... 20, 55, 62, 128
activity median aerodynamic diameter (see AMAD) ................................................................... 25, 73, 211
adenocarcinomas................................................................................................................................... 13, 62
adsorbed.................................................................................................................... 165, 166, 168, 191, 204
adsorption.................................................................................................................................................. 168
alanine aminotransferase (see ALT) ........................................................................................................... 50
ALI (see annual limits on intake).............................................................................. 207, 208, 209, 210, 211
ALT (see alanine aminotransferase) ........................................................................................................... 50
AMAD (activity median aerodynamic diameter) ................. 14, 24, 25, 43, 61, 73, 74, 75, 80, 86, 131, 211
ambient air ................................................................................................................................ 167, 188, 192
annual limits on intake (see ALI).............................................................................................................. 207
bioaccumulation........................................................................................................................................ 191
bioconcentration factor ............................................................................................................................. 170
biokinetic .............................................................................................................................. 20, 91, 110, 144
biomarker .................................................................................................................. 127, 128, 142, 195, 205
blood cell count..................................................................................................................................... 14, 48
breast milk......................................................................................................................................... 188, 192
cancer........................4, 10, 11, 12, 13, 14, 15, 25, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 45, 49, 50, 54, 56,
58, 59, 60, 61, 62, 64, 66, 70, 126, 129, 131, 136, 138, 139, 140, 141, 142, 207, 213
carcinogen................................................................................................................................................. 211
carcinogenic ........................................................................................................................................ 21, 211
carcinogenicity............................................................................................................................................ 78
carcinoma ................................................................................................................................ 13, 62, 63, 130
carcinomas .......................................................................................................................................... 62, 130
cardiac arrhythmia ...................................................................................................................................... 52
cardiovascular ..................................................................................................................... 16, 46, 64, 65, 86
cardiovascular effects............................................................................................................................ 16, 46
chromosomal aberrations................................................................................................ 66, 69, 70, 140, 141
clearance ............................................... 25, 73, 75, 86, 88, 91, 93, 95, 98, 99, 110, 112, 113, 122, 129, 211
DAC (see derived air concentration) ........................................................................................ 207, 210, 211
death........... 13, 21, 25, 28, 29, 30, 31, 32, 35, 36, 43, 44, 45, 52, 58, 59, 60, 61, 62, 63, 64, 65, 71, 78, 140
derived air concentration (see DAC) ........................................................................................................ 207
elimination half-time................................................................................................................................... 86
elimination rate ........................................................................................................................................... 76
endocrine............................................................................................................................................. 52, 124
endocrine effects ......................................................................................................................................... 52
erythema...................................................................................................................................................... 19
fetus................................................................................................................................. 5, 82, 125, 141, 208
fractional absorption ........................................................................................................... 76, 122, 139, 140
gastrointestinal effects .............................................................................................................. 16, 46, 47, 64
general population................................................................................................................. 3, 5, 10, 78, 207
genotoxic............................................................................................................................... 21, 66, 128, 140
genotoxicity..................................................................................................................................... 66, 69, 71
geometric standard deviation (see GSD) .................................................................................................... 73
groundwater ...................................................................................................... 163, 164, 166, 168, 175, 176
GSD (see geometric standard deviation) .................................................................................. 73, 74, 85, 86
half-life...................................................................................................... 2, 88, 98, 105, 127, 145, 170, 190
hematological effects .......................................................................................................... 14, 47, 48, 49, 53
hematopoietic................................................................................................................ 14, 23, 27, 28, 47, 60
Dostları ilə paylaş: |